Skip to Main Content

Author Details

Robert G Bristow
University of Toronto
1989
305
71
PMIDPaper TitleJournal TitlePublished Year
36494221Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.Eur Urol2023
37187202Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.Lancet Oncol2023
36947986Systemic treatment of metastatic hormone-sensitive prostate cancer-upfront triplet versus doublet combination therapy.ESMO Open2023
37003085Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.Eur J Cancer2023
36610996A polygenic two-hit hypothesis for prostate cancer.J Natl Cancer Inst2023
36870608First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer.Radiother Oncol2023
32605887Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer.Eur Urol Oncol2022
35440417Corrigendum to "What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021" [Eur Urol 82(1):6-11].Eur Urol2022
35701060RadBone: bone toxicity following pelvic radiotherapy - a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy.BMJ Open2022
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
35450732Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.Eur Urol2022
36497365T-Cell Infiltration and Clonality May Identify Distinct Survival Groups in Colorectal Cancer: Development and Validation of a Prognostic Model Based on The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC).Cancers (Basel)2022
36481612Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours.Nat Commun2022
35227733Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts.Radiother Oncol2022
35317841A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.Mol Cancer2022
35188214Conversations with LGBT+ scientists about visibility, leadership and climbing the career ladder.J Cell Sci2022
34667303Prostate zones and cancer: lost in transition?Nat Rev Urol2022
34538726Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy.Urol Oncol2022
33096102It's All the RAVE: Time to Give up on the "Chronic Radiation Proctitis" Misnomer.Gastroenterology2021
33685838Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.Eur Urol2021
33542230Prostate cancer.Nat Rev Dis Primers2021
33756422Lost in application: Measuring hypoxia for radiotherapy optimisation.Eur J Cancer2021
34824250The telomere length landscape of prostate cancer.Nat Commun2021
34642184Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors.Cancer Res2021
34716314Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse.Nat Commun2021
34743445Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.J Biomed Opt2021
34210300Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer.BMC Urol2021
34370973Prostate cancer.Lancet2021
33257424Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation.Clin Cancer Res2021
31161221Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome.J Natl Cancer Inst2020
32001144Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.Eur Urol2020
32024819Divergent mutational processes distinguish hypoxic and normoxic tumours.Nat Commun2020
31806542The tip of the iceberg: predicting PARP inhibitor efficacy in prostate cancer.Lancet Oncol2020
31974375Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer.Nat Commun2020
33217316Impact of Lineage Plasticity to and from a Neuroendocrine Phenotype on Progression and Response in Prostate and Lung Cancers.Mol Cell2020
32743555Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma.NAR Cancer2020
32797086Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.PLoS Med2020
32391125Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.Oncotarget2020
32305726The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report.Eur J Cancer2020
32147317Intermediate Risk Prostate Cancer: Disease Heterogeneity Linked to Measurable Biological Features.Clin Oncol (R Coll Radiol)2020
32551913Bad neighbours: hypoxia and genomic instability in prostate cancer.Br J Radiol2020
32175659Specific requirements for translation of biological research into clinical radiation oncology.Mol Oncol2020
32327479[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial.BMJ Open2020
30686350Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.Clin Genitourin Cancer2019
31665182Correction: Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma.PLoS One2019
31735626Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors.Cancer Cell2019
30170099Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy.Int J Radiat Oncol Biol Phys2019
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
30808988The influence of BRCA2 mutation on localized prostate cancer.Nat Rev Urol2019
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
  • 1 - 50 of 305

Recommended Authors

Pedro Isaacsson Velho
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Career Start Year 2013
Number of shared co-authors 17
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 24
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 7
Susana Miranda
The Institute of Cancer Research
Career Start Year 2008
Number of shared co-authors 32
Alan H Bryce
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 21
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 10
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 52
Serah Choi
University Hospitals Cleveland Medical Center and Case Comprehensive Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 24
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 19
Daniel S Higginson
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 9
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 23
Wassim Abida
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 44
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 23
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Career Start Year 1999
Number of shared co-authors 39
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 5
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 28
Leena Latonen
Foundation for the Finnish Cancer Institute
Career Start Year 1999
Number of shared co-authors 6
Sean M McBride
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 18
Simeng Suy
MedStar Georgetown University Hospital
Career Start Year 1996
Number of shared co-authors 9
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Career Start Year 1995
Number of shared co-authors 60
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 41
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 59
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 27
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 32
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 49
Suzanne Carreira
The Institute of Cancer Research
Career Start Year 1990
Number of shared co-authors 35
James M Ford
Stanford University
Career Start Year 1989
Number of shared co-authors 9
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 59
Alan Pollack
University of Miami Miller School of Medicine
Career Start Year 1963
Number of shared co-authors 39

Collaborators

Paul C Boutros
University of California los angeles
Co-authored papers 52
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 46
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 43
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 42
Richard P Hill
Princess Margaret Cancer Centre
Co-authored papers 30
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 25
Alice Meng
Tufts University School of Medicine
Co-authored papers 21
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 21
Neil E Fleshner
University of Toronto
Co-authored papers 18
Alan Dal Pra
University of Miami Miller School of Medicine
Co-authored papers 17
Jenna Sykes
St. Michael's Hospital, University of Toronto
Co-authored papers 17
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers 16
Gaetano Zafarana
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 14
Julie Livingstone
University of California los angeles
Co-authored papers 14
Takafumi N Yamaguchi
University of California los angeles
Co-authored papers 13
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 13
John Thoms
Memorial University
Co-authored papers 13
Vincent Huang
Ontario Institute for Cancer Research
Co-authored papers 13
Emilie Lalonde
University of Pennsylvania
Co-authored papers 12
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers 12
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 11
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 11
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Co-authored papers 10
Fred Saad
University of Montreal Health Center
Co-authored papers 10
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers 10
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 10
Martin E Gleave
University of British Columbia
Co-authored papers 10
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Co-authored papers 9
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 9
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 9
Release 1.2